An international team of researchers, led by one of Indian origin, has demonstrated that a drug used to treat kidney diseases can be safely administered to patients who are hospitalised for acute myocardial infarction -- heart attack. 

The team led by Mount Sinai Fuster Heart Hospital demonstrated that the drug empagliflozin can reliably lower heart failure episodes in individuals who have had a heart attack, regardless of the patient`s pre-existing renal function.